All Stories

  1. The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2

    Article • Antiviral Research, December 2015, Elsevier

    Dr Hans Jurgen Netter

  2. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity

    Article • Journal of Virology, September 2015, ASM Journals

    Dr Hans Jurgen Netter

  3. Immunogenicity of Malaria Vaccine Candidate - Plasmodium Falciparum Merozoite Surface Protein 5 (PfMSP5) Expressed in Bacillus subtilis

    Article • APCBEE Procedia, January 2014, Elsevier

    Dr Hans Jurgen Netter

  4. Anti-hepatitis B activity of isoquinoline alkaloids of plant origin

    Article • Archives of Virology, December 2013, Springer Science + Business Media

    Dr Hans Jurgen Netter

  5. Production, characterization, and immunogenicity of a secreted form of Plasmodium falciparum merozoite surface protein 4 produced in Bacillus subtilis

    Article • Applied Microbiology and Biotechnology, October 2013, Springer Science + Business Media

    Dr Hans Jurgen Netter

  6. Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells

    Article • Vaccine, April 2013, Elsevier

    Dr Hans Jurgen Netter

  7. Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits

    Article • Antiviral Research, February 2012, Elsevier

    Dr Hans Jurgen Netter

  8. Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix

    Article • Journal of Virological Methods, June 2009, Elsevier

    Dr Hans Jurgen Netter, Dr Heidi E Drummer

  9. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope

    Article • Antiviral Research, February 2009, Elsevier

    Dr Hans Jurgen Netter

  10. Host-range and pathogenicity of hepatitis B viruses

    Article • Future Virology, January 2008, Future Medicine

    Dr Hans Jurgen Netter

  11. Characterization of nonconventional hepatitis B viruses lacking the core promoter

    Article • Virology, December 2004, Elsevier

    Dr Hans Jurgen Netter

  12. Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine

    Article • Vaccine, June 2003, Elsevier

    Dr Hans Jurgen Netter

  13. Identification and Analysis of a New Hepadnavirus in White Storks

    Article • Virology, October 2001, Elsevier

    Dr Hans Jurgen Netter

  14. Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes

    Article • Journal of Virology, March 2001, ASM Journals

    Dr Hans Jurgen Netter

  15. A New Avian Hepadnavirus Infecting Snow Geese (Anser caerulescens) Produces a Significant Fraction of Virions Containing Single-Stranded DNA

    Article • Virology, September 1999, Elsevier

    Dr Hans Jurgen Netter

  16. Hepatitis Delta Virus

    Article • January 1995, Springer Science + Business Media

    Dr Hans Jurgen Netter

  17. Characterization of cDNA encoding the mouse hepatic triglyceride lipase and expression by in vitro translation

    Article • FEBS Letters, September 1991, Wiley

    Dr Hans Jurgen Netter

  18. Repetitive p68-autoantigen specific epitopes recognized by human anti-(U1) small nuclear ribonucleoprotein autoantibodies

    Article • Journal of Autoimmunity, August 1991, Elsevier

    Dr Hans Jurgen Netter

  19. A recombinant autoantigen derived from the human (u1) small nuclear rnp-specific 68-kd protein

    Article • Arthritis & Rheumatism, May 1988, Wiley

    Dr Hans Jurgen Netter